학술논문
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
Document Type
Article
Author
Skinner, S Rachel; Szarewski, Anne; Romanowski, Barbara; Garland, Suzanne M; Lazcano-Ponce, Eduardo; Salmerón, Jorge; Del Rosario-Raymundo, M Rowena; Verheijen, René H M; Quek, Swee Chong; da Silva, Daniel P; Kitchener, Henry; Fong, Kah Leng; Bouchard, Céline; Money, Deborah M; Ilancheran, Arunachalam; Cruickshank, Margaret E; Levin, Myron J; Chatterjee, Archana; Stapleton, Jack T; Martens, Mark; Quint, Wim; David, Marie-Pierre; Meric, Dorothée; Hardt, Karin; Descamps, Dominique; Geeraerts, Brecht; Struyf, Frank; Dubin, Gary
Source
In The Lancet 20 December 2014-2 January 2015 384(9961):2213-2227
Subject
Language
ISSN
0140-6736